Influence of plasma matrix metalloproteinase levels on longitudinal changes in Alzheimer's disease (AD) biomarkers and cognitive function in patients with mild cognitive impairment due to AD registered in the Alzheimer's Disease Neuroimaging Initiative database

Document Details

Document Type
Pub Defense Publication
Publication Date
Sep 01, 2020
Source ID
10.1016/j.jns.2020.116989

Entities

People

  • Akira Suda
  • Akitoyo Hishimoto
  • Asuka Yoshimi
  • Kie Abe
  • Omi Katsuse
  • Saki Hattori
  • Takeshi Asami
  • Yuhei Chiba

Organizations

  • Japan Society for the Promotion of Science
  • National Institutes of Health
  • United States Department of Defense